Skip to main navigation Skip to search Skip to main content

Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome

  • E. Bojesen S
  • , O. Ammerpohl
  • , Andreas Weinhäusel
  • , Oskar Athur Haas
  • , H. Mettal
  • , M. Bohle R
  • , A. Borkhardt
  • , U. Fuchs
  • Clinic for General Surgery and Thoracic Surgery, University Hospital of Schleswig-Holstein
  • Children's Cancer Research Institute
  • Dr von Haunersches Kinderspital, Department of Haematology/Oncology, Munich

Research output: Contribution to journalArticlepeer-review

Abstract

We report the isolation of the 5' flanking region of GRAF (GTPase regulator associated with the focal adhesion kinase), previously described as a putative tumour suppressor gene of acute myelogenous leukaemia and myelodysplastic syndrome, and demonstrate its promoter activity in reporter gene assays. Two putative protein-binding sites are identified of which one was sensitive to CpG methylation. The suppressed GRAF expression could be restored in leukaemia cell lines by treatment with a demethylating agent and an inhibitor of histone deacetylases. In contrast to normal tissues, which tested negative for GRAF promoter methylation, 11 of 29 (38%) bone marrow samples from patients with acute myeloid leukaemia or myelodysplastic syndrome were positive.
Original languageEnglish
Pages (from-to)323-332
Number of pages10
JournalBritish Journal of Cancer
Volume94
Publication statusPublished - 2006

Research Field

  • Not defined

Keywords

  • GRAF
  • AML
  • promoter methylation
  • MDS

Fingerprint

Dive into the research topics of 'Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome'. Together they form a unique fingerprint.

Cite this